Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
7
×
life sciences
national blog main
7
×
san francisco top stories
biotech
boston blog main
clinical trials
gene therapy
national top stories
new york top stories
san francisco blog main
boston top stories
deals
national
new york blog main
novartis
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco
bluebird bio
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
genentech
hemophilia
indiana blog main
indiana top stories
medicaid
medical device
raleigh-durham top stories
seattle blog main
seattle top stories
spark therapeutics
spinal muscular atrophy
startups
texas blog main
texas top stories
wisconsin blog main
What
therapy
7
×
drug
fda
gene
patients
approved
deal
developers
friday
new
oral
therapeutics
age
agency
aimmune
allergy
approval
aren’t
atrophy
awarded
bigger
biggest
bio
building
chemistry
cmc
come
consistent
controls
daily
daunting
developed
developer
disease
drugs
emerging
ensure
established
evrysdi
firm
Language
unset
Current search:
therapy
×
fda
×
" national blog main "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed